Timothy Mark Dyer 13D and 13G filings for Addex Therapeutics Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-05 4:00 pm Unchanged | 2023-04-04 | 13D | Addex Therapeutics Ltd ADXN | Timothy Mark Dyer | 492,766 11.090% | 0 (Unchanged) | Filing |
| 2023-03-31 4:00 pm Unchanged | 2023-03-30 | 13D | Addex Therapeutics Ltd ADXN | Timothy Mark Dyer | 492,766 12.180% | 0 (Unchanged) | Filing |
| 2022-11-23 06:00 am Unchanged | 2022-11-14 | 13D | Addex Therapeutics Ltd ADXN | Timothy Mark Dyer | 492,766 13.540% | 0 (Unchanged) | Filing |
| 2022-11-09 4:00 pm Purchase | 2022-10-26 | 13D | Addex Therapeutics Ltd ADXN | Timothy Mark Dyer | 492,766 20.010% | 269,741 (+120.95%) | Filing |
| 2022-08-05 06:01 am Purchase | 2022-07-26 | 13D | Addex Therapeutics Ltd ADXN | Timothy Mark Dyer | 223,025 8.400% | 41,476 (+22.85%) | Filing |
| 2021-09-08 06:01 am Purchase | 2021-08-30 | 13D | Addex Therapeutics Ltd ADXN | Timothy Mark Dyer | 181,549 9.730% | 38,172 (+26.62%) | Filing |